These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3050520)

  • 21. [From insulin secretion to insulin therapy].
    Soltani D; Perlemuter L
    Presse Med; 1998 Jul 4-11; 27(24):1240-6. PubMed ID: 9767787
    [No Abstract]   [Full Text] [Related]  

  • 22. Insulin secretion in type 2 diabetes: clinical aspects.
    Boitard C
    Diabetes Metab; 2002 Dec; 28(6 Suppl):4S33-8. PubMed ID: 12703063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statins associated with 46% rise in type 2 diabetes risk, study shows.
    Mayor S
    BMJ; 2015 Mar; 350():h1222. PubMed ID: 25742711
    [No Abstract]   [Full Text] [Related]  

  • 25. [From obesity to diabetes or the natural history of abnormalities in the secretion and action of insulin].
    Scheen AJ
    Rev Med Liege; 1992 Jul; 47(7):325-37. PubMed ID: 1636074
    [No Abstract]   [Full Text] [Related]  

  • 26. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus.
    Polonsky KS; Given BD; Hirsch LJ; Tillil H; Shapiro ET; Beebe C; Frank BH; Galloway JA; Van Cauter E
    N Engl J Med; 1988 May; 318(19):1231-9. PubMed ID: 3283554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of rapid insulin secretion: revisited.
    Grodsky GM
    Diabetes Technol Ther; 1999; 1(3):259-60. PubMed ID: 11475271
    [No Abstract]   [Full Text] [Related]  

  • 28. Insulin resistance causes increased beta-cell mass but defective glucose-stimulated insulin secretion in a murine model of type 2 diabetes.
    Asghar Z; Yau D; Chan F; Leroith D; Chan CB; Wheeler MB
    Diabetologia; 2006 Jan; 49(1):90-9. PubMed ID: 16362284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variable effects of statins on glucose homeostasis parameters and their diabetogenic role.
    Kostapanos MS; Agouridis AP; Elisaf MS
    Diabetologia; 2015 Aug; 58(8):1960-1. PubMed ID: 26026652
    [No Abstract]   [Full Text] [Related]  

  • 30. Glucose toxicity: the implications of hyperglycemia in the pathophysiology of diabetes mellitus.
    Rossetti L
    Clin Invest Med; 1995 Aug; 18(4):255-60. PubMed ID: 8549010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term treatment with GLP-1 increases pulsatile insulin secretion in Type II diabetes with no effect on orderliness.
    Juhl CB; Schmitz O; Pincus S; Holst JJ; Veldhuis J; Pørksen N
    Diabetologia; 2000 May; 43(5):583-8. PubMed ID: 10855533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormalities of insulin pulsatility and glucose oscillations during meals in obese noninsulin-dependent diabetic patients: effects of weight reduction.
    Gumbiner B; Van Cauter E; Beltz WF; Ditzler TM; Griver K; Polonsky KS; Henry RR
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2061-8. PubMed ID: 8964829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-frequency insulin pulsatility and type 2 diabetes: from physiology and pathophysiology to clinical pharmacology.
    Schmitz O; Brock B; Hollingdal M; Juhl CB; Pørksen N
    Diabetes Metab; 2002 Dec; 28(6 Suppl):4S14-20. PubMed ID: 12703061
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin secretion and insulin sensitivity in diabetic subgroups: studies in the prediabetic and diabetic state.
    Tripathy D; Carlsson AL; Lehto M; Isomaa B; Tuomi T; Groop L
    Diabetologia; 2000 Dec; 43(12):1476-83. PubMed ID: 11151756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leptin levels in type 2 diabetes: associations with measures of insulin resistance and insulin secretion.
    Wauters M; Considine RV; Yudkin JS; Peiffer F; De Leeuw I; Van Gaal LF
    Horm Metab Res; 2003 Feb; 35(2):92-6. PubMed ID: 12734788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired pulsatile insulin secretion: causal defect or epiphenomenon of type 2 diabetes?
    Schrezenmeir J; Strack T; Beyer J
    Diabet Med; 1989 Mar; 6(2):178-9. PubMed ID: 2522866
    [No Abstract]   [Full Text] [Related]  

  • 38. Pathogenesis and treatment of type 2 (noninsulin-dependent) diabetes mellitus (NIDDM).
    Gerich JE
    Horm Metab Res; 1996 Sep; 28(9):404-12. PubMed ID: 8911974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspects of the pathogenesis of type 2 diabetes.
    Efendić S; Luft R; Wajngot A
    Endocr Rev; 1984; 5(3):395-410. PubMed ID: 6381035
    [No Abstract]   [Full Text] [Related]  

  • 40. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.